Champions Oncology announced on July 18, 2025, that its Board of Directors has appointed Rob Brainin as the new Chief Executive Officer. Mr. Brainin will also join the Board of Directors, with his appointment effective August 25, 2025.
Rob Brainin has been a member of Champions Oncology's Board of Directors since 2021, bringing prior experience and familiarity with the company's operations and strategic goals. He will succeed Dr. Ronnie Morris, who has served as CEO since 2017.
This leadership transition marks a significant change at the helm of Champions Oncology. The appointment of an existing board member to the CEO role suggests a focus on continuity while bringing fresh perspectives to drive the company's strategic initiatives forward.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.